[go: up one dir, main page]

GB9701710D0 - Mammalian protein - Google Patents

Mammalian protein

Info

Publication number
GB9701710D0
GB9701710D0 GBGB9701710.7A GB9701710A GB9701710D0 GB 9701710 D0 GB9701710 D0 GB 9701710D0 GB 9701710 A GB9701710 A GB 9701710A GB 9701710 D0 GB9701710 D0 GB 9701710D0
Authority
GB
United Kingdom
Prior art keywords
mammalian protein
mammalian
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9701710.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Karo Healthcare AB
Original Assignee
Karo Bio AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karo Bio AB filed Critical Karo Bio AB
Priority to GBGB9701710.7A priority Critical patent/GB9701710D0/en
Publication of GB9701710D0 publication Critical patent/GB9701710D0/en
Priority to JP53176098A priority patent/JP2001510997A/ja
Priority to AU57745/98A priority patent/AU5774598A/en
Priority to KR1019997006829A priority patent/KR20000070582A/ko
Priority to EP98901415A priority patent/EP1012296A2/fr
Priority to CA002279241A priority patent/CA2279241A1/fr
Priority to PCT/GB1998/000263 priority patent/WO1998032863A2/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0036—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on NADH or NADPH (1.6)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Vascular Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9701710.7A 1997-01-28 1997-01-28 Mammalian protein Pending GB9701710D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9701710.7A GB9701710D0 (en) 1997-01-28 1997-01-28 Mammalian protein
JP53176098A JP2001510997A (ja) 1997-01-28 1998-01-28 哺乳類チオレドキシン
AU57745/98A AU5774598A (en) 1997-01-28 1998-01-28 Mammalian thioredoxin
KR1019997006829A KR20000070582A (ko) 1997-01-28 1998-01-28 포유류의 단백질
EP98901415A EP1012296A2 (fr) 1997-01-28 1998-01-28 Thioredoxine mammalienne
CA002279241A CA2279241A1 (fr) 1997-01-28 1998-01-28 Thioredoxine mammalienne
PCT/GB1998/000263 WO1998032863A2 (fr) 1997-01-28 1998-01-28 Thioredoxine mammalienne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9701710.7A GB9701710D0 (en) 1997-01-28 1997-01-28 Mammalian protein

Publications (1)

Publication Number Publication Date
GB9701710D0 true GB9701710D0 (en) 1997-03-19

Family

ID=10806693

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9701710.7A Pending GB9701710D0 (en) 1997-01-28 1997-01-28 Mammalian protein

Country Status (7)

Country Link
EP (1) EP1012296A2 (fr)
JP (1) JP2001510997A (fr)
KR (1) KR20000070582A (fr)
AU (1) AU5774598A (fr)
CA (1) CA2279241A1 (fr)
GB (1) GB9701710D0 (fr)
WO (1) WO1998032863A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4790891B2 (ja) * 2000-02-02 2011-10-12 オリエンタル酵母工業株式会社 溶液中で安定なチオレドキシン組成物およびその製法
CA2414586C (fr) * 2000-06-29 2009-09-29 Mitsubishi Pharma Corporation Agent de traitement therapeutique des maladies du nerf optique et de maladies semblables
FR2823221B1 (fr) 2001-04-06 2004-04-02 Univ Pasteur Sequences associees a la degenerescence retinienne et applications
JP4925155B2 (ja) * 2002-06-10 2012-04-25 レドックス・バイオサイエンス株式会社 網膜神経細胞機能回復剤
US7825161B2 (en) * 2003-12-15 2010-11-02 Nano-C, Inc. Higher fullerenes useful as radical scavengers
WO2005087249A1 (fr) * 2004-03-11 2005-09-22 Kurume University Inhibiteur de prothèse et préventifs ou remèdes pour maladies.
CN104062294A (zh) * 2014-07-11 2014-09-24 青岛千士医疗科技有限公司 一种支气管/肺上皮细胞线粒体损伤的检测方法
WO2019168364A1 (fr) * 2018-03-02 2019-09-06 사회복지법인 삼성생명공익재단 Procédé de régulation à la hausse de l'expression de thiorédoxine dans des cellules souches

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69011465T2 (de) * 1989-09-29 1995-03-23 Ajinomoto Kk Verwendung von Human-ADF (=Adult T-cell leukemia-derived factor) zur Herstellung von Medikamenten.

Also Published As

Publication number Publication date
AU5774598A (en) 1998-08-18
EP1012296A2 (fr) 2000-06-28
KR20000070582A (ko) 2000-11-25
CA2279241A1 (fr) 1998-07-30
JP2001510997A (ja) 2001-08-07
WO1998032863A2 (fr) 1998-07-30
WO1998032863A3 (fr) 1998-11-05

Similar Documents

Publication Publication Date Title
GB9718609D0 (en) Fusion protein
HUP0100436A3 (en) Mammalian cytokine-like polypeptide-10
ZA9710338B (en) Proteins
IL133582A0 (en) Mammalian neuro-growth factor like protein
GB9510830D0 (en) Proteins
GB9719879D0 (en) Protein
GB9703681D0 (en) Protein complemention
GB9701710D0 (en) Mammalian protein
GB9715064D0 (en) Protein expression
IL143052A0 (en) Mammalian chondromodulin-like protein
ZA984322B (en) Sucrose-binding proteins
AU6000698A (en) Proteins
GB9720784D0 (en) Protein
AU6275098A (en) Novel h-rev 107-like protein
ZA971900B (en) Modified proteins
GB9722003D0 (en) Proteins
GB9722727D0 (en) Proteins
GB9703104D0 (en) Proteins
GB9707822D0 (en) Proteins
GB9700121D0 (en) Proteins
GB9707499D0 (en) Proteins
GB9703827D0 (en) Novel protein
GB9706119D0 (en) Novel protein
GB9703850D0 (en) Novel protein
GB9704252D0 (en) Novel protein